Mostrar el registro sencillo del ítem
Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples:: Analysis by site of isolation
dc.contributor.author | Guinea, Jesus | |
dc.contributor.author | Pelaez, Teresa | |
dc.contributor.author | Alcala, L | |
dc.contributor.author | Ruiz-Serrano, Maria Jesus | |
dc.contributor.author | Bouza, Emilio | |
dc.date.accessioned | 2024-02-06T11:55:43Z | |
dc.date.available | 2024-02-06T11:55:43Z | |
dc.date.issued | 2005-08-01 | |
dc.identifier.citation | Guinea, J., Peláez, T., Alcalá, L., Ruiz-Serrano, M. J., & Bouza, E. (2005). Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrobial agents and chemotherapy, 49(8), 3495–3497. https://doi.org/10.1128/AAC.49.8.3495-3497.2005 | es |
dc.identifier.issn | 0066-4804 | |
dc.identifier.other | https://journals.asm.org/journal/aac | es |
dc.identifier.uri | http://hdl.handle.net/20.500.12020/1255 | |
dc.description.abstract | We analyzed the activities of six antifungal drugs (amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin, and micafungin) against 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples. We did not find differences among the susceptibilities by site of isolation. | es |
dc.language.iso | en | es |
dc.publisher | American Society for Microbiology | es |
dc.title | Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples:: Analysis by site of isolation | es |
dc.type | article | es |
dc.identifier.doi | 10.1128/AAC.49.8.3495-3497.2005 | |
dc.issue.number | 8 | es |
dc.journal.title | Antimicrobial Agents and Chemotherapy | es |
dc.page.initial | 3495 | es |
dc.page.final | 3497 | es |
dc.relation.projectID | This study was partially financed by research funds from the Comunidad de Madrid (CAM Ref. 08.2/0026/2001 1) and by grant number 02/0016-1 from Fondos de Investigación Sanitaria and from Red Española de Investigació en Patologı´a Infecciosa C/03/14 (REIPI) | es |
dc.rights.accessRights | embargoedAccess | es |
dc.subject.area | Ciencias Biomédicas | es |
dc.subject.keyword | In-vitro susceptibility | es |
dc.subject.keyword | Amphotericin B | es |
dc.subject.keyword | Itraconazole resistance | es |
dc.subject.keyword | Invasive aspergillosis | es |
dc.subject.keyword | Voriconazole | es |
dc.subject.keyword | Caspofungin | es |
dc.subject.unesco | 3201.03 Microbiología Clínica | es |
dc.volume.number | 49 | es |
Ficheros en el ítem
Fichero/s | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |